Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Paroxysmal Nocturnal Hemoglobinuria Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
The International Biotechnology Center (IBC) Generium
Ra Pharmaceuticals, Inc
Omeros Corporation
Akari Therapeutics, Plc
Epirus Biopharmaceuticals, Inc
Amyndas Pharmaceuticals LLC
Alexion Pharmaceuticals, Inc
Regenesance BV
Achillion Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc
By Type:
ALN-CC5
APL-2
ALXN-1210
AMY-101
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Overview 2018-2029
-
1.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Development Overview
-
1.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Development History
-
1.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Market Size (2018-2029)
-
1.4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis by Type from Production Side
-
1.4.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of ALN-CC5 (2018-2029)
-
1.4.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of APL-2 (2018-2029)
-
1.4.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of ALXN-1210 (2018-2029)
-
1.4.4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of AMY-101 (2018-2029)
-
1.5 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis by Region
-
1.6.1 North China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Paroxysmal Nocturnal Hemoglobinuria Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Development
Chapter 3 Paroxysmal Nocturnal Hemoglobinuria DrugsIndustry Chain Analysis
-
3.1 Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Chain
-
3.2 Paroxysmal Nocturnal Hemoglobinuria Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Paroxysmal Nocturnal Hemoglobinuria Drugs Market
-
3.3 Paroxysmal Nocturnal Hemoglobinuria Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Paroxysmal Nocturnal Hemoglobinuria Drugs Market
Chapter 4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
4.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of ALN-CC5
-
4.5.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of APL-2
-
4.5.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of ALXN-1210
-
4.5.4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of AMY-101
Chapter 5 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Paroxysmal Nocturnal Hemoglobinuria Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 1
-
5.5.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 2
-
5.5.3 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 3
Chapter 6 China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Region
-
6.1 China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Production Value, by Region
-
6.2 China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
7.1 North China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
7.2 North China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 8 Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
8.1 Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
8.2 Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 9 South China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
9.1 South China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
9.2 South China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 10 East China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
10.1 East China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
10.2 East China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 11 Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
11.1 Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
11.2 Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 12 Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
12.1 Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
12.2 Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 13 Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Analysis
-
13.1 Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Type
-
13.2 Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 The International Biotechnology Center (IBC) Generium
-
14.1.1 The International Biotechnology Center (IBC) Generium Company Profile
-
14.1.2 The International Biotechnology Center (IBC) Generium Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Ra Pharmaceuticals, Inc
-
14.2.1 Ra Pharmaceuticals, Inc Company Profile
-
14.2.2 Ra Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Omeros Corporation
-
14.3.1 Omeros Corporation Company Profile
-
14.3.2 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Akari Therapeutics, Plc
-
14.4.1 Akari Therapeutics, Plc Company Profile
-
14.4.2 Akari Therapeutics, Plc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Epirus Biopharmaceuticals, Inc
-
14.5.1 Epirus Biopharmaceuticals, Inc Company Profile
-
14.5.2 Epirus Biopharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Amyndas Pharmaceuticals LLC
-
14.6.1 Amyndas Pharmaceuticals LLC Company Profile
-
14.6.2 Amyndas Pharmaceuticals LLC Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Alexion Pharmaceuticals, Inc
-
14.7.1 Alexion Pharmaceuticals, Inc Company Profile
-
14.7.2 Alexion Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Regenesance BV
-
14.8.1 Regenesance BV Company Profile
-
14.8.2 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Achillion Pharmaceuticals, Inc
-
14.9.1 Achillion Pharmaceuticals, Inc Company Profile
-
14.9.2 Achillion Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Alnylam Pharmaceuticals, Inc
-
14.10.1 Alnylam Pharmaceuticals, Inc Company Profile
-
14.10.2 Alnylam Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Research Conclusions
-
15.2 Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Market Size (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of ALN-CC5 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of APL-2 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of ALXN-1210 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume, Production Value and Growth Rate of AMY-101 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate from 2018-2029
-
Figure Paroxysmal Nocturnal Hemoglobinuria Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Share by Type in 2018
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Share by Type in 2023
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of ALN-CC5 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of APL-2 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of ALXN-1210 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume and Growth Rate of AMY-101 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Share by Application in 2018
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Share by Application in 2023
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Region (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Value by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Value Share by Region (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Value Share by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Value by Region (2018-2023)
-
Table China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Value Share by Region (2018-2023)
-
Figure China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Value Share by Region (2018-2023)
-
Table North China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table North China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table North China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table North China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table South China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table South China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table South China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table East China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table East China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table East China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Paroxysmal Nocturnal Hemoglobinuria Drugs Sales Volume Share by Application (2018-2023)
-
Table The International Biotechnology Center (IBC) Generium Company Profile
-
Table The International Biotechnology Center (IBC) Generium Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Ra Pharmaceuticals, Inc Company Profile
-
Table Ra Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Omeros Corporation Company Profile
-
Table Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Akari Therapeutics, Plc Company Profile
-
Table Akari Therapeutics, Plc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Epirus Biopharmaceuticals, Inc Company Profile
-
Table Epirus Biopharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Amyndas Pharmaceuticals LLC Company Profile
-
Table Amyndas Pharmaceuticals LLC Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Alexion Pharmaceuticals, Inc Company Profile
-
Table Alexion Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Regenesance BV Company Profile
-
Table Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Achillion Pharmaceuticals, Inc Company Profile
-
Table Achillion Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals, Inc Company Profile
-
Table Alnylam Pharmaceuticals, Inc Paroxysmal Nocturnal Hemoglobinuria Drugs Revenue, Price and Gross (2018-2023)
-
